Shahrokh Shabahang

Shahrokh Shabahang founded Sekris Biomedical, Inc. in 2009, where he is working as Chairman & Chief Executive Officer from 2009 and Aditxt, Inc. in 2017, where he is working as Director & Chief Innovation Officer from 2017.
Dr. Shabahang also formerly worked at Loma Linda University, as Director-Microbiology and Genelux Corp., as Secretary from 2004 to 2007.
Dr. Shabahang received his doctorate degree in 2001 from Loma Linda University and doctorate degree in 1987 from the University of the Pacific.